Key Takeaways
- WES captures ~85% of known disease-causing mutations residing in coding exons at cost-effective high read depths.
- WGS eliminates PCR hybridization capture artifacts, providing vastly superior coverage uniformity across GC-rich promoters.
- Structural variants (SVs), balanced translocations, and copy number alterations (CNVs) are detected with significantly higher sensitivity in WGS.
- WGS generates ~90–120 GB of raw data per sample compared to ~6–10 GB for WES, demanding scalable storage and compute pipelines.
How Do Genomic Targets and Capture Technologies Compare?
In human and mammalian genetics, determining the optimal sequencing modality represents a critical balance between cost, depth, and genomic territory:
- The Exome (WES Territory): In the human genome (GRCh38), protein-coding exons constitute approximately 30 to 45 megabases (Mb), representing merely 1.5% to 2% of the total 3.2 gigabase genome. WES isolates these targets by hybridizing sheared genomic DNA libraries against synthetic biotinylated RNA/DNA oligonucleotide probe pools (e.g., Twist Human Core Exome, Agilent SureSelect, or Illumina Exome Panel), followed by streptavidin magnetic bead separation.
- The Whole Genome (WGS Territory): WGS skips target enrichment entirely. Genomic DNA is sheared, end-repaired, adapter-ligated, and sequenced directly. It queries the entire genome, encompassing coding exons, introns, 5' and 3' untranslated regions (UTRs), promoters, distant enhancers, non-coding RNAs, and intergenic regions.
Why Does Coverage Uniformity Differ Dramatically Between WGS and WES?
A widespread misconception is that 100x mean coverage in WES is uniformly superior to 30x mean coverage in WGS. In reality, hybridization capture introduces severe technical variability:
- GC Bias and Probe Dropouts: Hybridization kinetics depend heavily on base composition. Exons with extreme GC content (e.g., >70% GC in first exons and CpG islands) or extreme AT content hybridize inefficiently to probes, causing localized "dropouts" where actual read depth falls to zero despite a 100x global average.
- Off-Target Capture: In typical WES protocols, 20% to 35% of reads align outside designated target intervals due to non-specific probe annealing, wasting sequencing capacity.
- WGS Coverage Uniformity: PCR-free WGS workflows avoid amplification and probe biases entirely. A 30x WGS run typically delivers >95% of the genome covered at ≥20x depth, including difficult GC-rich promoter regions that frequently fail in exome capture kits.
How Do They Compare for Variant Calling: SNVs, Indels, and Structural Variants?
The choice of assay dictates the analytical spectrum of detectable variants:
- Single Nucleotide Variants (SNVs) & Small Indels: WES is exceptionally sensitive for discovering rare, high-penetrance coding SNVs and small insertions/deletions (<20 bp) within canonical exons. Because sequencing depth is high (80x to 120x), confidence in heterozygous variant calls is very robust. WGS achieves comparable SNV accuracy at 30x depth due to higher alignment quality and lower PCR duplicate rates.
- Copy Number Variations (CNVs): WES detects CNVs by comparing normalized read depths across non-contiguous exon targets using tools like CNVkit or ExomeDepth. However, breakpoint resolution is coarse, and small multi-exon deletions are frequently missed. In contrast, WGS provides continuous read-depth tracking and paired-end discordant read signatures, resolving CNV boundaries with base-pair precision.
- Structural Variants (SVs): Inversions, complex translocations, and retrotransposon insertions predominantly have breakpoints in non-coding intronic or intergenic space. Because WES sequences only coding exons, these breakpoints are invisible. WGS, especially when paired with long-read technologies (PacBio, Oxford Nanopore), is the gold standard for comprehensive structural variation analysis.
What Computational Infrastructure and Storage are Required?
The sheer scale of genomic data directly impacts data management budgets:
| Operational Metric | Whole-Exome Sequencing (WES) | Whole-Genome Sequencing (WGS) |
|---|---|---|
| Mean Target Depth | 80x to 120x | 30x to 40x |
| Raw Data per Sample | 6 to 12 GB (FASTQ.gz) | 90 to 130 GB (FASTQ.gz) |
| Final Alignment (BAM/CRAM) | ~4 GB BAM | ~60 GB BAM / ~20 GB CRAM |
| Typical Pipeline Runtime | 1 to 3 CPU hours (BWA + GATK) | 15 to 30 CPU hours (or accelerated GPU/DRAGEN) |
| Primary Clinical Focus | Mendelian disorders, pediatric rare disease, targeted oncology | Unsolved rare disease, population genetics, structural biology |
When Should a Research Lab Choose WES vs WGS?
Decision frameworks generally hinge on specific research hypotheses:
- Choose WES When:
- The primary goal is identifying coding mutations responsible for high-penetrance Mendelian genetic traits.
- Sequencing hundreds of cohort individuals under fixed grant funding constraints.
- Somatic tumor-normal sequencing where ultra-deep coverage (>200x) is required to detect low-frequency subclonal mutations.
- Choose WGS When:
- Prior exome sequencing yielded negative or inconclusive diagnostic results in family trios.
- The hypothesis involves non-coding regulatory variants (promoters, enhancers, deep intronic splice alterations).
- Characterizing complex chromosomal rearrangements, copy number alterations, or mobile element insertions.
- Investigating non-model agricultural or microbial organisms lacking commercial exome capture probe sets.
Need High-Precision Variant Calling for Your Samples?
Xenoi Biotech processes both Whole-Exome and Whole-Genome sequencing data using containerized GATK and DeepVariant Nextflow pipelines. Receive coordinate-sorted CRAMs, calibrated VCFs, and comprehensive ClinVar/gnomAD annotations.
Further Reading & Benchmark Studies
- WGS vs WES Diagnostic Yield: Belkadi, A., et al. (2015). Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants. Proceedings of the National Academy of Sciences, 112(17), 5473–5478. doi:10.1073/pnas.1418631112
- GATK Best Practices: Van der Auwera, G. A., & O'Connor, B. D. (2020). Genomics in the Cloud: Using Docker, GATK, and WDL in Terra. O'Reilly Media.
- DeepVariant Neural Network Calling: Poplin, R., et al. (2018). A universal SNP and small-indel variant caller using deep neural networks. Nature Biotechnology, 36(10), 983–989. doi:10.1038/nbt.4235
- Structural Variation Benchmarking: Chaisson, M. J. P., et al. (2019). Multi-platform discovery of haplotype-resolved structural variation in human genomes. Nature Communications, 10(1), 1784. doi:10.1038/s41467-018-08148-z